Cargando…
Rejuvenating immunity: “anti-aging drug today” eight years later
The 2014 year ended with celebration: Everolimus, a rapamycin analog, was shown to improve immunity in old humans, heralding ‘a turning point’ in research and new era in human quest for immortality. Yet, this turning point was predicted a decade ago. But what will cause human death, when aging will...
Autor principal: | Blagosklonny, Mikhail V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637294/ https://www.ncbi.nlm.nih.gov/pubmed/25844603 |
Ejemplares similares
-
From rapalogs to anti-aging formula
por: Blagosklonny, Mikhail V.
Publicado: (2017) -
Common drugs and treatments for cancer and age-related diseases: revitalizing answers to NCI's provocative questions
por: Blagosklonny, Mikhail V.
Publicado: (2012) -
MTOR-driven quasi-programmed aging as a disposable soma theory: Blind watchmaker vs. intelligent designer
por: Blagosklonny, Mikhail V.
Publicado: (2013) -
Towards disease-oriented dosing of rapamycin for longevity: does aging exist or only age-related diseases?
por: Blagosklonny, Mikhail V.
Publicado: (2023) -
Are menopause, aging and prostate cancer diseases?
por: Blagosklonny, Mikhail V.
Publicado: (2023)